• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Venture Capital

fundraise tracker 2026
Biotech

Fierce Biotech Fundraising Tracker '26: Abcuro, InduPro & more

Welcome to Fierce Biotech’s Fundraising Tracker for 2026.
Will Maddox , Darren Incorvaia , James Waldron , Gabrielle Masson , Marissa Russo Aug 18, 2026 8:50am
two arrows pointing different directions

Slate uses Fulcrum to join Nasdaq with $245M for migraine trials

Aug 17, 2026 9:30am
Close-up of Benjamin Franklins eyes peering through hundred dollar bills

Pfizer vet debuts Khartis with sights set on thyroid eye disease

Aug 13, 2026 9:00am
cash money

Epicrispr bags $90M to rewrite treatment of rare muscle disease

Aug 11, 2026 10:30am
Saplings growing with increasing denominations of money wrapped around them

Regeneron backs $75M series A for antibody upstart Infinimmune

Aug 11, 2026 8:00am
Network of blood vessels against a white background

Vaderis' $152M to fund ph. 3 trial in rare blood vessel disorder

Aug 11, 2026 7:00am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings